Dapagliflozin in Patients With a Failing Systemic Right Ventricle
JACC: Heart Failure · 2024-04 · 12 (4) · 789-791
DOI: 10.1016/j.jchf.2024.01.006 ↗Kurz gefasst
Leserbrief in der Zeitschrift JACC: Heart Failure, 2024-04. Verfasst von Flavia Fusco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Monaldi Hospital, Naples, Italy. Electronic address: flavia.fusco@ospedalideicolli.it. Hauptthemen laut MEDLINE: Heart Failure, Diabetes Mellitus, Type 2, Glucosides. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Monaldi Hospital, Naples, Italy. Electronic address: flavia.fusco@ospedalideicolli.it.
- Monaldi Hospital, Naples, Italy.
Zitieren
APA
Fusco, F., Scognamiglio, G., Abbate, M., Merola, A., Grimaldi, N., Ciriello, G. D., & Sarubbi, B. (2024). Dapagliflozin in Patients With a Failing Systemic Right Ventricle. JACC: Heart Failure, 12(4), 789-791. https://doi.org/10.1016/j.jchf.2024.01.006
Vancouver
Fusco F, Scognamiglio G, Abbate M, Merola A, Grimaldi N, Ciriello GD, et al. Dapagliflozin in Patients With a Failing Systemic Right Ventricle. JACC: Heart Failure. 2024;12(4):789-791. doi:10.1016/j.jchf.2024.01.006
BibTeX
@article{Fusco2024,
author = {Fusco, Flavia and Scognamiglio, Giancarlo and Abbate, Massimiliana and Merola, Assunta and Grimaldi, Nicola and Ciriello, Giovanni Domenico and Sarubbi, Berardo},
title = {Dapagliflozin in Patients With a Failing Systemic Right Ventricle},
journal = {JACC: Heart Failure},
year = {2024},
volume = {12},
number = {4},
pages = {789--791},
doi = {10.1016/j.jchf.2024.01.006}
}
EUVIMED